Back to Search Start Over

The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry.

Authors :
Younossi ZM
Yilmaz Y
El-Kassas M
Duseja A
Hamid S
Esmat G
Méndez-Sánchez N
Chan WK
Singal AK
Lam B
Felix S
Younossi E
Verma M
Price JK
Nader F
Younossi I
Racila A
Stepanova M
Source :
Hepatology communications [Hepatol Commun] 2022 Oct; Vol. 6 (10), pp. 2860-2866. Date of Electronic Publication: 2022 Jul 26.
Publication Year :
2022

Abstract

Patients with preexisting chronic liver disease (CLD) may experience a substantial burden from both coronavirus 2019 (COVID-19) infection and pandemic-related life disruption. We assessed the impact of the COVID-19 pandemic on patients with CLD. Patients enrolled in our Global Liver Registry were invited to complete a COVID-19 survey. As of June 2021, 2500 patients (mean age ± SD, 49 ± 13 years; 53% men) from seven countries completed the survey. Of all survey completers, 9.3% had COVID-19. Of these patients, 19% were hospitalized, 13% needed oxygen support, but none required mechanical ventilation. Of all patients including those not infected with COVID-19, 11.3% reported that the pandemic had an impact on their liver disease, with 73% of those reporting delays in follow-up care. The Life Disruption Event Perception questionnaire confirmed worsening in at least one area (food/nutrition, exercise, social life, vocation/education, financial situation, housing, or health care) in 81% and 69% of patients with and without a history of COVID-19, respectively (p = 0.0001). On a self-assessed Likert health score scale (range, 1-10; 10 indicates perfect health), patients with a COVID-19 history scored lower (mean ± SD, 6.7 ± 2.2 vs. 7.4 ± 2.2, respectively; p < 0.0001) despite reporting similar health scores if there was no pandemic (mean ± SD, 8.5 ± 1.4 vs. 8.4 ± 1.6, respectively; p = 0.59). After adjustment for country of enrollment, liver disease etiology and severity, age, sex, body mass index, diabetes, and history of psychiatric comorbidities, COVID-19 was found to be independently associated with lower self-assessed health scores (beta = -0.71 ± 0.14; p < 0.0001). The COVID-19 pandemic resulted in a substantial burden on the daily life of patients with CLD.<br /> (© 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.)

Details

Language :
English
ISSN :
2471-254X
Volume :
6
Issue :
10
Database :
MEDLINE
Journal :
Hepatology communications
Publication Type :
Academic Journal
Accession number :
35880475
Full Text :
https://doi.org/10.1002/hep4.2048